Log on / register
Feedback | Support | My details
HIV-1 latency in actively dividing human T cell lines.
Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B
Retrovirology 2008, 5:37
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
The utilization of humanized mouse models for the study of human retroviral infections
Van Duyne R, Pedati C, Guendel I, Carpio L, Kehn-Hall K, Saifuddin M, Kashanchi F
Retrovirology 2009, 6:76 (12 August 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

2.


Short report    
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
Savarino A, Mai A, Norelli S, El Daker S, Valente S, Rotili D, Altucci L, Palamara AT, Garaci E
Retrovirology 2009, 6:52 (2 June 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

3.


Review    
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Coleman CM, Wu L
Retrovirology 2009, 6:51 (1 June 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]

4.


Editorial    
The 2008 Retrovirology Prize: Ben Berkhout and his RNA world
Jeang KT
Retrovirology 2008, 5:113 (11 December 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

5.


Commentary    
The aftermath of the Merck's HIV vaccine trial
Iaccino E, Schiavone M, Fiume G, Quinto I, Scala G
Retrovirology 2008, 5:56 (2 July 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]


This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.